Affiliation:
1. P.A.Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre
2. A.F.Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological Center
Abstract
Currently the main way of curable treatment of hepatocellular carcinomas (HCC)* is a liver resection. Candidates for surgery are patient with good score of liver function (Child-Pugh A group), without destruction of great vessels and distant metastases. Hemihepatectomy is associated with a high risk of postoperative liver failure (including portal hypertension, cirrhosis, portal vein thrombosis). This reason leads to premature failure of the operation. According to current clinical guidelines, system therapy is more suitable, despite of the lack of reliable data on its effectiveness in such clinical situations. The presented cases may support the selection of advanced hemihepatectomy as a treatment for hepatocellular cancer C stage BCLC classification.
Subject
Microbiology (medical),Immunology,Immunology and Allergy
Reference15 articles.
1. Steger U, Kellersmann A, Germer CT. Hemihepatektomie. Zentralblatt für Chirurgie. 2016; 141(03): 253–255. https://doi.org/10.1055/s-0042–102535
2. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC), Korea. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver. 2019; (3): 227–299. https://doi.org/10.5009/gnl1902
3. Bruera G, Cannita K, Giordano AV, Manetta R, Vicentini R, Carducci S, et. al. Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice. Biomed Res Int. 2014; 2014: 806391. https://doi.org/10.1155/2014/806391
4. Dimitroulis D, Damaskos C, Valsami S, Davakis S. Garmpis N, Spartalis E, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017 Aug 7; 23(29): 5282–5294. https://doi.org/10.3748/wjg.v23.i29.5282
5. Marreroa JA, Kudob M, Bronowickic J P. The Challenge of Prognosis and Staging for Hepatocellular Carcinoma. The Onologist, 2010. https://doi.org/10.1634/theoncologist.2010-S4–23
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献